We have successful products – including the blockbuster Lidoderm® patch – but our teams are continuing to develop innovative products to address unmet needs in the market. We are known for developing and manufacturing complex formulations entirely in house that are difficult for competitors to replicate.
Teikoku Pharma USA (TPU), a subsidiary of Teikoku Seiyaku, Japan, is a family-owned, privately-held international specialty pharmaceutical company founded in 1997 in California.
We develop innovative products in several therapeutic areas, including pain management, CNS disorders, dermatology, and oncology, using our proprietary and innovative drug delivery platforms, including patches, injectables, gels, creams, and ointments. Our team can take an asset from conception to FDA approval, including R&D, clinical, regulatory, and manufacturing.
Teikoku Seiyaku has a storied history of technological innovation and business success.